A research study in Peru to test an intervention called DIALOG+ designed to improve care for people living in the community with severe mental illness

Testing the effectiveness, acceptability and feasibility of DIALOG+ in severe mental illness in Peru: a non-controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN38360953

Enrollment

Registered

2019-07-08

Start date

2019-07-15

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with severe mental illness (including psychosis, bipolar disorder and severe depression) Mental and Behavioural Disorders

Interventions

At least 5 clinicians, and 40 patients will be recruited. Patients will receive DIALOG+ at their routine clinical appointments once per month. This will be delivered by their usual clinician using an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of severe mental illness as defined by ICD10: F20-9, F31, F32 2. Aged 18-65 years old 3. Capacity to provide informed consent 4. Score of 5 or below on the MANSA scale 5. Receiving care from a participating health care provider

Exclusion criteria

Exclusion criteria: 1. Diagnosis of dementia or organic psychosis as determined by their health providers 2. Primary diagnosis of substance use disorder 3. Severe learning difficulties or severe cognitive disability

Design outcomes

Primary

Measure	Time frame
Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA) at baseline and 6 months	—

Secondary

Measure	Time frame
1. Objective social functioning, measured using the Objective Social Outcome Index (SIX) at baseline and 6 months 2. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline and 6 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline and 6 months 4. Patients' experience of the DIALOG+ intervention assessed using qualitative interviews at 6 months	—

Measure

Time frame

1. Objective social functioning, measured using the Objective Social Outcome Index (SIX) at baseline and 6 months 2. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline and 6 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline and 6 months 4. Patients' experience of the DIALOG+ intervention assessed using qualitative interviews at 6 months

—

Countries

Peru

Contacts

Public ContactFrancois van Loggerenberg

f.vanloggerenberg@qmul.ac.uk+44 (0)207 540 4380 Ext: 2339

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026